Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancers Lymphatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00940342
What this trial is testing

Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 130
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Early research (Phase 1)Looking for participantsNCT07586618
What this trial is testing

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Who this might be right for
Lymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL
Allterum Therapeutics, Inc 24
Testing effectiveness (Phase 2)Study completedNCT00006390
What this trial is testing

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Very early researchLooking for participantsNCT07548697
What this trial is testing

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

Who this might be right for
B-cell Non Hodgkin Lymphoma (NHL)DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT04826523
What this trial is testing

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 150
Early research (Phase 1)Study completedNCT02323880
What this trial is testing

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Who this might be right for
Malignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more
Children's Oncology Group 59
Testing effectiveness (Phase 2)UnknownNCT04935580
What this trial is testing

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 20
Early research (Phase 1)Study completedNCT00058396
What this trial is testing

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Not applicableNot Yet RecruitingNCT06785870
What this trial is testing

EVAluation of Erythrocytosis PRospEctive Cohort STudy

Who this might be right for
ErythrocytosisPolycythemiaPolycythemia Secondary+5 more
Cyrus Hsia 1,500
Testing effectiveness (Phase 2)Ended earlyNCT02078960
What this trial is testing

Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 10
Testing effectiveness (Phase 2)WithdrawnNCT05125562
What this trial is testing

Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19

Who this might be right for
COVID-19
Direct Biologics, LLC
Large-scale testing (Phase 3)Study completedNCT00005596
What this trial is testing

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 1,076
Post-approval studies (Phase 4)Looking for participantsNCT06876662
What this trial is testing

(LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company 279
Not applicableUnknownNCT03440788
What this trial is testing

Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin

Who this might be right for
Relapsed or Refractory Hodgkin's Lymphoma
Multinational Center for Quality of Life Research, Russia 70
Early research (Phase 1)Looking for participantsNCT06088888
What this trial is testing

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Shenzhen TargetRx Co., Ltd. 90
Testing effectiveness (Phase 2)Looking for participantsNCT07029503
What this trial is testing

Swedish Cardiac And Renal Failure Study-1

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionChronic Kidney Disease
Karolinska Institutet 40
Not applicableStudy completedNCT03720561
What this trial is testing

Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen-Cilag S.p.A. 312
Next Page